N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide

Basic Information

View in Editor

CAS Number

198470-84-7

Molecular Formula

C19H18N2O4S

Molecular Weight

370.43 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Physical State

No data available

Melting Point

153.0 to 157.0 deg-C

Boiling Point

°Cat760mmHg

Refractive Index

1.58

SMILES

View in Editor

CCC(=O)NS(=O)(=O)c1ccc(cc1)c2c(C)onc2c3ccccc3

InChI

InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22)

InChIKey

TZRHLKRLEZJVIJ-UHFFFAOYSA-N

LogP

3.531920000000002

Topological Polar Surface Area

89.27 Å²

Hydrogen Bond Donor/Acceptor

1 / 6

Complexity

575

Safety Information

View Safety Information

Hazard Statement

H360 May damage fertility or the unborn child
Reproductive toxicity

H373 Causes damage to organs through prolonged or repeated exposure
Specific target organ toxicity, repeated exposure

Synonyms & References

English

Parecoxib
Dynastat
Parocoxib
SC 69124
N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide
N-[4-(5-methyl-3-phenyl-oxazol-4-yl)phenyl]sulfonylpropanamide
N-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide
Parecoxib [USAN:INN:BAN]
Propanamide, N-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-
UNII-9TUW81Y3CE
N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide
N-{[4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl]sulfonyl}propionamide
N-[[4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl]sulfonyl]propionamide (This product is unavailable in the U.S.)
N-[4-(5-Methyl-3-phenyloxazol-4-yl)phenyl]sulfonylpropanamide
Valus-P
Vorth-P
Valdecoxib Impurity J
Parecoxib SodiuM IMpurity W
Parecoxib SodiuM iMpurity PR-12-I
N-(4-(5-Methyl-3-phenylisoxazol-4-yl)phenylsulfonyl)propionaMide
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide

MDL Number

MFCD08141856

FAQ

What regulatory guidelines apply to N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide (CAS: 198470-84-7)?

N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide (CAS: 198470-84-7) is subject to regulatory guidelines under the Globally Harmonized System (GHS) for classification and labeling of chemicals. For production and import/export, it must comply with REACH regulations in the European Union, which include the need for Safety Data Sheets (SDS) and registration with the European Chemicals Agency (ECHA). In the United States, it is regulated by the FDA for pharmaceutical purposes and the EPA for environmental and toxicological concerns.

Are there alternatives to N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide (CAS: 198470-84-7) in synthesis?

There are several alternatives to N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide (CAS: 198470-84-7) in synthesis, including analogs such as N-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}butanamide and isomers like N-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}ethanamide. Common alternative reagents include sulfonyl chloride derivatives and other amide-forming reagents, such as N-hydroxysuccinimide or carbodiimides, which can be used in place of the specific sulfonyl group in the synthesis of similar compounds.

What is the market or research trend for N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide (CAS: 198470-84-7)?

The market for N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide (CAS: 198470-84-7) is closely linked to its use in pharmaceutical and research applications. Research trends indicate a growing interest in its potential as an intermediate for the development of novel drugs. Market dynamics show increasing demand in the pharmaceutical industry, driven by the need for new and effective therapeutic agents. Price trends are influenced by supply chain dynamics and the competitive landscape of the pharmaceutical sector.

How should waste containing N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide (CAS: 198470-84-7) be handled?

Waste containing N-{[4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide (CAS: 198470-84-7) should be collected and stored in dedicated containers to prevent environmental contamination. For disposal, it should be handled according to local and national regulations, typically involving incineration or professional waste disposal services that specialize in hazardous waste. Environmental protection precautions include proper labeling, minimizing exposure, and ensuring compliance with all relevant environmental protection guidelines and regulations.